Haemonetics Corp rises on Friday as it acquires Vivasure Medical for $100 millionSee details
Haemonetics Corp - HAE - stock price prediction, stock price target, analyst ratings from 11 analysts
Haemonetics Corp has a share price target of US$ 90, revenue growth forecast of -3.1%, and profit growth estimate of 10.4% for FY26, based on top 11 analyst calls.